Intracranial Pressure and Brain Function: Effects of Head Down Tilt Upon Brain Perfusion and Cognitive Performance

NCT ID: NCT02976168

Last Updated: 2017-03-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to understand the relationship between intracranial pressure regulation, cerebral tissue oxygenation and cognitive functioning. More specifically, the study tests the hypothesis that head down tilt will increase intracranial pressure (not measured in this study, but demonstrated in previous studies), will induce venous congestion and facial swelling, decrease intracranial tissue oxygenation and hamper brain functioning. The objectives of the study therefore are to assess young healthy people during head-down tilt (HDT), and to assess cognitive brain functioning, cerebral tissue oxygenation (non-invasively), frontal skin thickness, cerebral perfusion and neuronal functioning via event-related potentials.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracranial Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Horizontal

Subjects will be in horizontal supine Position for 21 hours

Group Type NO_INTERVENTION

No interventions assigned to this group

-12° head down tilt

Subjects will be in 12° head down supine Position for 21 hours

Group Type EXPERIMENTAL

12° head down tilt

Intervention Type OTHER

supine head down tilt

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

12° head down tilt

supine head down tilt

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Physically and mentally healthy male test subjects that are able and declare in writing their willingness to participate in the entire study and successfully passed the psychological and medical screening
* Aged between 18-55 years old with a Body Mass Index (BMI) of 20-28 kg/m2, weight between 65-100 kg, and a height between 158-195 cm
* Demonstrable medical insurance and official certificate of absence of criminal record

Exclusion Criteria

* Inability to sleep on the back
* Drug, medication or alcohol abuse (regular consumption of more than 20-30 g alcohol/day)
* Smoking within the past 6 months prior to study commencement
* Migraine or other chronic head aches
* Previous psychiatric illness
* Subjects suffering from weak concentration
* History of psychological or central nervous disorders
* Hiatus hernia
* Gastro-oesophageal reflux
* Diabetes mellitus
* Pronounced orthostatic intolerance (\< 10 min standing)
* Kidney disorder: deviations from normal values for creatinine in plasma. (Normal value: Creatinine \< 1.20 mg/dl)
* Thyroid gland disorder: deviations from normal values for thyroid stimulating Hormone (TSH) in plasma. (Normal range: TSH 0.55-4.80 mUnits/l)
* Anaemia: Hb under normal values (Normal values of Hb for men: 13.5-17.5 g/l)
* Elevated risk of thrombosis
* High likelihood of coagulopathy assessed by a clinical standard questionnaire
* Chronic back complaints
* History of lumbar surgery
* History of lumbar spine trauma
* Motor or sensory deficits as assessed by neurological examination
* Contraindications against MRI
* Imprisoned at the time of the study
* Taking medications that may impair cognitive function, autonomic function or any of the study procedures
* Ophthalmological conditions including glaucoma, retinopathy, severe cataracts, eye trauma or implants
* Any other medical condition that the investigators consider a contraindication to the study procedures that would make it unsafe or confound the measurements.
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Forschungszentrum Juelich

OTHER

Sponsor Role collaborator

University Hospital, Umeå

OTHER

Sponsor Role collaborator

University of Cologne

OTHER

Sponsor Role collaborator

DLR German Aerospace Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jörn E Rittweger, MD

Role: PRINCIPAL_INVESTIGATOR

German Aerospace Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

DLR German Aerospace Center

Cologne, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Boschert AL, Elmenhorst D, Gauger P, Li Z, Garcia-Gutierrez MT, Gerlach D, Johannes B, Zange J, Bauer A, Rittweger J. Sleep Is Compromised in -12 degrees Head Down Tilt Position. Front Physiol. 2019 Apr 16;10:397. doi: 10.3389/fphys.2019.00397. eCollection 2019.

Reference Type DERIVED
PMID: 31040791 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IPCog

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brainstem and Prematurity
NCT02669056 COMPLETED NA